secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2025-07-28T23:59:59+00:00
Accession:  0001641172-25-021085
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Impact BioMedical to issue 31.9M shares to DSS to settle $12M debt
------------------------------------------------------------------

- Issued 31,939,778 shares of common stock to DSS Inc. to fully satisfy $12M revolving promissory note from March 2023.
- Original note was amended Jan 2024 to extend maturity to Sept 30, 2023, eliminate advance feature, set repayment terms, adjust interest to WSJ Prime + 0.5%.
- Shares are freely tradeable and settle all amounts owed under the note and any additional support between June 21, 2025 and closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000164117225021085/0001641172-25-021085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000164117225021085/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-021085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer